Dr. Lokesh Rukmangadachar, MD

Dr. Rukmangadachar practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Rukmangadachar's NPI, 1255763561, was assigned on August 8, 2013. Dr. Rukmangadachar graduated from Mysore Medical College in 2005. Dr. Rukmangadachar holds Texas license U2627.

Dr. Rukmangadachar's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Rukmangadachar's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Rukmangadachar is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple. Dmand AI also links Dr. Rukmangadachar to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rukmangadachar practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rukmangadachar's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rukmangadachar is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Rukmangadachar's licenses on file in 4 states: Texas, Missouri, California and Illinois.

Dmand AI lists fibromyalgia and chronic pain, head injury, hereditary polyneuropathy, lower back pain, migraine and chronic headache, mobility impairment, multiple sclerosis and muscle disease among the conditions Dr. Rukmangadachar treats.

CMS data shows 308 Medicare services from Dr. Rukmangadachar across 4 procedure codes in 2024, all of them office visits, for 250 Medicare patients. Medicare paid $31,012 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 250 Medicare patients who saw Dr. Rukmangadachar in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rukmangadachar's median patient age at 70, with 64% women.

In 2024, Dr. Rukmangadachar wrote 719 Medicare Part D claims for 203 patients. 88% of them were for generic drugs. CMS names the drug for 485 of them, across 15 drugs with 11 or more claims each, at $507,000 in total drug cost. In 2023, CMS named 494 claims across 18 drugs.

Dr. Rukmangadachar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rukmangadachar as offering telehealth.

Dmand AI links 11 papers to Dr. Rukmangadachar, published from 2011 to 2024. 2011 was the busiest year, with 2. The most frequent topics are Proteomics and Tandem Mass Spectrometry. Dr. Rukmangadachar has published most often in Cureus. Dr. Rukmangadachar's most frequent co-authors are Osasu Noel Adah, MD, Esther Noni Bit-Ivan, DO and Sudeepta Dandapat, MD.

CMS Open Payments shows 43 general payments to Dr. Rukmangadachar from 9 drug and device companies from 2017 to 2025. Grants make up the largest share, 92% of the total. Biogen, Inc. paid the most, $95,823.

Dr. Rukmangadachar graduated from Mysore Medical College in 2005.

Dr. Rukmangadachar is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.